This Regulation determines the undertaking of measures related to the suppression and eradication of the infectious disease Nodular dermatitis, determined by the decision of the Ministry of Agriculture and Environmental Protection-Veterinary Administration, No. 323-02-05119 / 2016-05 of 7 June 2016, for the purpose of preventing the spread of the infectious disease Nodular dermatitis by determining the mode of import and administration of the vaccine against the infectious disease Nodular dermatitis-Dermatitis nodosa (Lumpy Skin Disease). There is no specific treatment for animals infected with the infectious disease such as Nodular dermatitis. In epizootic conditions, vaccination can be carried out with a homologous live attenuated vaccine, or a heterologous attenuated vaccine. Currently, no new generation of recombinant Capripox vaccine is available on the market of the Republic of Serbia.
Serbia · 2016-06-13